# Maxcyte, Inc.: Form SCHEDULE 13D, filed Oct 24, 2025

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: SCHEDULE 13D
- Filed: 2025-10-24
- Accepted by EDGAR: Oct 24, 2025, 11:50 ET
- Period: not reported
- Accession: 0001486180-25-000006
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000148618025000006/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000148618025000006/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000148618025000006/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001486180-25-000006. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.